Mezcla de enzimas Gateway™ LR Clonase™
Product Image
Invitrogen™

Mezcla de enzimas Gateway™ LR Clonase™

La mezcla de enzimas Gateway® LR Clonase® contiene una mezcla patentada de enzimas Int (integrasa), IHF (factor de integración delMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
11791043100 reacciones
1179101920 reacciones
Número de catálogo 11791043
Precio (CLP)
5.121.392
Each
Añadir al carro de la compra
Cantidad:
100 reacciones
Precio (CLP)
5.121.392
Each
Añadir al carro de la compra
La mezcla de enzimas Gateway® LR Clonase® contiene una mezcla patentada de enzimas Int (integrasa), IHF (factor de integración del huésped) y Xis (excisionasa) que cataliza la recombinación in vitro entre un clon de entrada (que contiene un gen de interés flanqueado por sitios attL) y un vector de destino (que contiene sitios attR) para generar su clon de expresión. Ofrecemos diferentes formatos de mezclas de enzimas LR Clonase, en función de la aplicación y el formato deseado. La mezcla de enzimas LR Clonase II Plus es la última versión que ofrece la máxima eficacia de recombinación disponible (Tabla 1) y está específicamente optimizada para la clonación de fragmentos únicos y múltiples (Tabla 1). La mezcla de enzimas LR Clonase II Plus se suministra en una sola mezcla optimizada de tampón de reacción y enzima, lo que garantiza la estabilidad de la enzima y la facilidad de uso con pocos pasos de pipeteo para la clonación de fragmentos individuales y múltiples. Nuestra mezcla de enzimas LR Clonase II también está disponible en un formato de una sola mezcla, mientras que en la enzima LR Clonase® original la enzima y el tampón se suministran en tubos separados

Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.

Especificaciones
Tampón compatibleTampón de reacción
Tipo de productoMezcla de enzimas LR Clonase
Cantidad100 reacciones
Condiciones de envíoHielo seco
EnzimaLR Clonase
Línea de productosClonase, Gateway
Unit SizeEach
Contenido y almacenamiento
Todos los kits de enzimas Gateway™ LR Clonase™ incluyen una solución de proteinasa K (2 µg/µl) y un vector de control positivo. Almacene la enzima LR Clonase™ a - 80 °C y las mezclas de enzimas LR Clonase™ II o II Plus a - 20 °C. Se garantiza la estabilidad durante 6 meses si se almacena correctamente.

Preguntas frecuentes

I performed an LR reaction and got high background after transformation. Can you please offer some troubleshooting tips?

– Check whether the reaction was transformed into an E.coli strain containing the F' episome and the ccdA gene – use an E.coli strain that does not contain the F&339; episome, e.g. OmniMAX 2-T1R, TOP10.
– Deletion (full or partial) of the ccdB gene – propagate in media with 50-100 mg/mL ampicillin and 15-30 µg/mL chloramphenicol.
– Contamination from another resistant strain.
– Check whether proper amount of DNA was used in the reaction.

I performed an LR reaction and got two distinct types of colonies (large and small) after transformation. What could be the possible reasons?

– Plasmid was lost during culture due to large size or toxicity – try incubating at 30 degrees C; use Stbl2 E.coli to stabilize the plasmid.
– Deletions (full or partial) or point mutations in the ccdB gene – obtain a new Destination vector.
– Small colonies may be unreacted entry clone that co-transforms with the Expression clone – reduce the amount of Entry clone to 50 ng per 10 µL reaction; reduce the volume of sample used for transformation to 1 µL; for a Destination vector with ampicillin selection marker, increase the ampicillin concentration to 300 µg/mL.

I performed an LR reaction and got no colonies after transformation, and the recombination positive control was not successful. Can you please offer some suggestions?

– Check the competent cells with pUC19 transformation.
– Increase the amount plated.

I performed an LR reaction and got few or no colonies after transformation, whereas the transformation control gave colonies. Can you please offer some suggestions?

– Increase the incubation time up to 18 hours.
– Make sure to treat reactions with proteinase K before transformation.
– Check whether the correct antibiotic was used for selection.
– Check whether the att site sequences are correct.
– Check whether the correct Clonase enzyme was used and whether it was functional.
– Check whether the recommended amount of DNA was used in the reaction.
– Perform the positive control recombination with pENTR-Gus plasmid.
– If the Entry clone or Destination vector is too large (>10 kb), incubate the LR reaction overnight, linearize the Destination vector or the Entry clone or relax the Destination vector with topoisomerase I.

Can I create a single Entry vector for use with DEST vectors that have N-terminal tags and C-terminal tags?

No, since a stop codon would be necessary for an N-terminal tagged destination vector, whereas the presence of a stop codon would block expression of the C-terminal tag.

Citations & References (4)

Citations & References
Abstract
High-throughput yeast two-hybrid assays for large-scale protein interaction mapping.
Authors:Walhout AJ, Vidal M,
Journal:Methods
PubMed ID:11403578
'Protein-protein interactions play fundamental roles in many biological processes. Hence, protein interaction mapping is becoming a well-established functional genomics approach to generate functional annotations for predicted proteins that so far have remained uncharacterized. The yeast two-hybrid system is currently one of the most standardized protein interaction mapping techniques. Here, we ... More
Functional identification of Arabidopsis stress regulatory genes using the controlled cDNA overexpression system.
Authors:Papdi C, Abrahám E, Joseph MP, Popescu C, Koncz C, Szabados L,
Journal:Plant Physiol
PubMed ID:18441225
'Responses to environmental stresses in higher plants are controlled by a complex web of abscisic acid (ABA)-dependent and independent signaling pathways. To perform genetic screens for identification of novel Arabidopsis (Arabidopsis thaliana) loci involved in the control of abiotic stress responses, a complementary DNA (cDNA) expression library was created in ... More
Homologous high-throughput expression and purification of highly conserved E coli proteins.
Authors:Ergin A, Büssow K, Sieper J, Thiel A, Duchmann R, Adam T,
Journal:Microb Cell Fact
PubMed ID:17553160
BACKGROUND: Genetic factors and a dysregulated immune response towards commensal bacteria contribute to the pathogenesis of Inflammatory Bowel Disease (IBD). Animal models demonstrated that the normal intestinal flora is crucial for the development of intestinal inflammation. However, due to the complexity of the intestinal flora, it has been difficult to ... More
Human protein factory for converting the transcriptome into an in vitro-expressed proteome,.
Authors:Goshima N, Kawamura Y, Fukumoto A, Miura A, Honma R, Satoh R, Wakamatsu A, Yamamoto J, Kimura K, Nishikawa T, Andoh T, Iida Y, Ishikawa K, Ito E, Kagawa N, Kaminaga C, Kanehori K, Kawakami B, Kenmochi K, Kimura R, Kobayashi M, Kuroita T, Kuwayama H, Maruyama Y, Matsuo K, Minami K, Mitsubori M, Mori M, Morishita R, Murase A, Nishikawa A, Nishikawa S, Okamoto T, Sakagami N, Sakamoto Y, Sasaki Y, Seki T, Sono S, Sugiyama A, Sumiya T, Takayama T, Takayama Y, Takeda H, Togashi T, Yahata K, Yamada H,
Journal:Nat Methods
PubMed ID:19054851
Appropriate resources and expression technology necessary for human proteomics on a whole-proteome scale are being developed. We prepared a foundation for simple and efficient production of human proteins using the versatile Gateway vector system. We generated 33,275 human Gateway entry clones for protein synthesis, developed mRNA expression protocols for them ... More